In the current study, we examined the role of Ezh2 as an epigenetic modifier for the enteric neural crest cell development through H3K27me3. Ezh2 conditional null mice were viable up to birth, but died within the first hour of life. In addition to craniofacial defects, Ezh2 conditional null mice displayed reduced number of ganglion cells in the enteric nervous system. RT-PCR and ChIP assays indicated aberrant up-regulation of Zic1, Pax3, and Sox10 and loss of H3K27me3 marks in the promoter regions of these genes in the myenteric plexus. Overall, these results suggest that Ezh2 is an important epigenetic modifier for the enteric neural crest cell development through repression of Zic1, Pax3, and Sox10.
Introduction
The neural crest cells (NCCs) are a multipotent cell population which have evolved among land vertebrates to develop a head, jaw, and sensory nervous system to adapt to predatory lifestyles (Gans and Northcutt, 1983) . The NCCs arise between the neural epithelium and epidermis after neurulation and migrate throughout the body to generate many different cell types. Depending on their rostro-caudal axis origin and cellular differentiation capabilities, NCCs can be divided into cranial, sacral, cardiac, trunk and vagal NCCs (Bhatt et al., 2013) . A number of different genes have been characterized to be important for the development of NCCs. Bone morphogenetic proteins (Bmps) and Wnt proteins induce NC formation. Pax3 and Zic1 specify the neural plate border (Betancur et al., 2010, Millet and Monsoro-Burq, 2012) , and Sox10 sustains NCC multipotency (Kim et al., 2014) . Hox genes, which are critical for body segmentation and axial patterning (Maconochie et al., 1996; Holland and Garcia-Fernández, 1996) , also affect the development of NCCs (Schwarz et al, 2014) . Mutations in these genes can lead to neurocristopathies, which encompass a wide range of congenital diseases of neural crest cell origin. In some examples of neurocristopathies, such as Hirshsprung's disease and Waardenburg syndrome, the enteric nervous system (ENS) is improperly developed, leading to intestinal aganglionosis in the distal portions of the colon (Moore and Johnson, 2005) . Most of the ENS develops from vagal NCCs, and some contribution of sacral NCC have been seen in mice and chicks (Serbedzija et al., 1991; Burns et al., 2000; Burns and Le Douarin, 2001 ).
Although a number of genes have been characterized to be associated with the neurocristopathies, the penetrance for the mutant allele of these genes varies suggesting a multigenic and potentially epigenetic involvement in manifestation of these disorders.
The polycomb group genes (PcGs) are epigenetic modifiers that play a significant role in regulating the expression of Hox genes and many other developmental transcription factors throughout embryonic development (Beuchle et al., 2001; Soshnikova and Duboule, 2009 ). The two major groups of PcGs include Polycomb repression complex 1 (PRC1) and Polycomb repression complex 2 (PRC2). These protein complexes are evolutionarily well conserved from flying insects to all mammals, including humans. These two complexes modify histones as an epigenetic signal: the ubiquitination on lysine 119 of histone 2B (H2BK119) by PRC1 and the methylation on lysine 27 of histone 3 (H3K27) by PRC2. In the case of PRC2, Enhancer of Zeste homolog 2 (Ezh2) is the histone methyltransferase, adding di-and tri-methyl groups to H3K27. The tri-methylation of H3K27 (H3K27me3) is usually associated with gene repression (Cao et al., 2002; Boyer et al., 2006; Barski et al., 2007) . Complete deletion of Ezh2 leads to early embryonic lethality (O'Carroll et al., 2001) , and tissue specific deletions of Ezh2 display loss of cellular differentiation (Zhang et al., 2015 , Ezhkova et al., 2009 ). In particular, deletion of Ezh2 in NCCs hinders the development of craniofacial bone structure in association with the de-repression of Hox genes in the first brachial arch (BA1) cells. In vitro culture of these BA1 cells demonstrated that differentiation factors such as GFAP and NF160 were properly expressed in Ezh2 conditional null cells (Schwarz et al., 2014) . However, these mutant NCCs have not been examined in later stages of embryonic development in vivo.
We performed a series of conditional knockout experiments targeting Ezh2 to examine the effect of PRC2 in neural crest cell development in later stages of embryogenesis focusing on the ENS development. In addition to aberrant facial structures, conditional ablation of Ezh2 in NCCs led to improper development of ganglion cells in the ENS and derepression of Pax3, Zic1, and Sox10.
Material and Methods

Animals
The Ezh2 conditional knockout mice were derived as previously described (Su et al., 2003) .
Presence of a loxP site insertion was confirmed through polymerase chain reaction (PCR) amplification with the following primers: LoxF-CCCATTGAGAGTGCTGACTCA; LoxR-ACCTCGCTATGTGTAACCAGT, and F3.1-TCTTAGCACTTGCTTGTTCCCATTG.
Expected fragment sizes were 100 bp without the loxP insertion and 120 bp with the loxP insertion (Fig. S1) . Template DNA was acquired through mouse ear clips that had been digested in tail lysis buffer (0.1 M Tris-Cl, 5 mM EDTA, 0.2% SDS, 0.2 M NaCl, pH 8.0, 20 µg/ml Proteinase K). E15.5 and E18.5 embryos were harvested through timed mating between
Ezh2
flox/flox ; Wnt1-Cre T/+ double mutant backcrossed with Ezh2 flox/flox . The survival curve was generated by combining four litters of cesarean sections (n= 40). Pups delivered through cesarean sections were massaged on the abdomen, and fluid was gently removed from the nasal and oral cavity using Kimwipes. The p value was derived using the Fisher exact statistical test.
All mouse work was approved by the IACUC committee at Louisiana State University.
Histology
Embryos and neonatal mice were fixed for 24-28 hours in 10% formalin and subsequently moved into 70% ethanol for storage. Tissue were trimmed and routinely embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E).
Toluidine blue staining
Toluidine blue staining was performed as previously described (Spazierer et al., 2006) . In brief, unfixed neonates were incubated in 100% methanol for 5 minutes and then stained in 0.1% toluidine blue dye for 20 minutes.
AChE staining
Acetylcholinesterase (AChE) staining was performed according to a previously described protocol (Enomoto et al., 1998) . In brief, the dissected stomach and intestines were fixed in 4% paraformaldehyde for 2 hours at 4°C and moved to saturated sodium sulfate solution overnight at 4°C. Then, the tissues were incubated in the staining buffer (0.2 mM ethopropazine HCl, 4 mM acetylthiocholine iodide, 10 mM glycine, 2 mM cupric sulfate, and 65 mM sodium acetate pH 5.5) for 4-5 hours at room temperature. Lastly, acetylcholinesterase staining was completed by incubating the stomach and intestines in 1.25% sodium sulfide pH 6 for 1.5 minutes.
RT-PCR
The whole gut and the myenteric plexus (according to Grundmann et al., 2016) was isolated and snap frozen in liquid nitrogen. After adding Trizol (Invitrogen) into frozen tissues, the tissues were further minced into smaller fragments with sterile scissors in Trizol. Tissue fractions in
Trizol were left on ice for 30 minutes and total RNA was isolated as described by manufacture's protocol (Invitrogen). Isolated RNA was resuspended in nuclease-free water and cDNA was synthesized with MMLV reverse transcriptase (Invitrogen) according to manufacture's protocol.
Chromatin immunoprecipitation assay
The P0 neonatal intestine was dissected and the myenteric plexus was isolated with Liberase TH (Roche) (Grundmann et al., 2016 
Whole mount RNA in situ hybridization
The E15 embryo guts were dissected and fixed in 4% PFA overnight in 4°C. The whole mount RNA in situ hybridization was performed as described previously (Zakin and De Robertis, 2004) with anti-Pax3 probe hybridization at 68°C. The images were captured with Olympus DP70 camera attached to the Olympus SZX7 stereo microscope.
Immunohistochemical procedures
The longitudinal muscle attached to the myenteric plexus (LMMP) was isolated from embryonic day 16 (E16) and P0 guts and fixed for 30 minutes in room temperature in 4%
paraformaldehyde. After twenty-minute treatment in 0.05% Triton-X in 1X PBS, the LMMPs were blocked for endogenous peroxidase activity by incubation in 3% hydrogen peroxide for one hour in room temperature. The LMMPs were pre-blocked in blocking solution (1% BSA, 0.3% 
Data analysis
The current data presented were obtained from at least three biological replicates from three different mice litters and at least two experimental replicates. The survival was assessed through The glial cells were counted in GFAP positive cluster in 300µm 2 area of at least eight images from four mice of each wild type and mutant genotypes. The statistical significance was tested through two-tailed Student's t-test. The density of the nerve fibers from the AChE staining were imaged in a set magnification and was quantified through skeletal reconstruction of the ganglion cells on image J and the number of intersections were counted and divided by the relative distance analyzed.
Results
Conditional knockout of Ezh2 in neural crest cells leads to perinatal lethality and abnormal facial structures
To characterize the function of Ezh2 during mouse NCC development, the mutant mice homozygous for the two loxP sites flanking exon 15 through 18 in 129P2/OlaHsd background were backcrossed with the Wnt1-Cre line in the 129/B6 mixed background, generating the Ezh2 homozygous mice in NCC (Ezh2 flox/flox ;Wnt1-Cre T/+ ; hereafter referred to as 'Ezh2 null' mice).
Exon deletion and subsequent reduced expression of Ezh2 were further confirmed through qRT-PCR (Fig. S1) . Analysis of early and late embryos from this cross showed the expected Mendelian ratios, while an increased number of dead Ezh2 null mutants were observed among the pups found within the first day of birth ( Consistent with the fact that the pinna develops from NCCs (Mallo, 2003) , the pinnae of the outer ear were not visible in any of Ezh2 null mice (n=30/30) (Figs 1D, 1E and Fig. S6 ). Some of the Ezh2 null mice displayed microphthalmia: the eye was approximately 2/3 the size of that in the wild-type littermates (n=5/10) (Fig. 1F) . Third, a protruding chest (or 'pigeon's chest'-like defect) was observed in some Ezh2 null pups (n=4/12) (Fig. 1B asterisks) . The Ezh2 null mice also exhibit defects in closure and merging of eyelids and upper lip (Figs 1H, 1J, and 1H ). We performed toluidine blue staining of the mice to characterize the epithelial permeability barrier. As expected, staining was detected only at the site of the non-developed eyelids of the Ezh2 null mice (Fig. 1I, and Fig. S5 ). The epithelial barrier was intact throughout the remaining face and body of the Ezh2 null neonatal pups, as the other areas of the body did not stain.
Histologically, the Ezh2 null neonatal pups had no cornea and conjunctiva, resulting in a malformed anterior segment of the eyes (Fig. 1H) . Non-NCC lineage structures, however, such as the retina and the uvea, were similarly developed as those in the wild-type littermates (Fig.   1H ). The Ezh2 null mice also displayed incomplete fusion of the nasal placode ( Fig. 1J and Fig.   S6 ). Gentle massaging of the stomach in Ezh2 null mutants after caesarian section released amniotic fluid from the mouth as it did in their wild-type littermates. This suggests that the oral cavity and the gastrointestinal tract are properly connected in the mutants. All mice, including the Ezh2 null mutants, also had well developed lungs, indicating adequate communication of the lower respiratory tract with the nasopharynx since fetal breathing of amniotic fluid is required for proper lung development. Overall, conditional deletion of Ezh2 in NCCs resulted in prenatal lethality and severe craniofacial defects.
Reduced number of ganglion cells in the enteric nervous system of Ezh2 null mice
The ganglion cells of the enteric nervous system (ENS) are also of NCC lineage. To examine proper development of ENS, series of AChE (acetylcholinesterase) histological staining were performed with the Ezh2 null mutants and the wild-type littermates (Enomoto et al, 1998) . The earliest visible difference in the morphology of these ganglion cells and nerve fibers through AChE staining was after E18.5, but was the most prominent in neonatal (P0) pups. Complete depletion of ganglion cells (aganglionosis) was visible in the distal colons of some Ezh2 null mice (n=3 of 7 Ezh2 null mice) (Fig. 2 -bottom panel) while milder reduction of ganglion cells (hypoganglionosis) were apparent in the other Ezh2 null mice (n=4 of 7 Ezh2 null mice) (Fig. 2 - middle panel). In the proximal colon, approximately 90% and 60% reduction of ganglion cells in comparison to its wild type littermate were displayed from the severe and mild cases of hypoganglionosis, respectively (p<0.0001) (Fig. 2) . In addition, the reduction of the enteric nervous system plexus was also observed in the small intestine and stomach of Ezh2 null mutants compared to those in the wild-type littermates (approximately 50% reduction, p=0.0011) (Fig.   S4 ). In sum, some of the Ezh2 null mice displayed aganglionosis in the distal colon and the hypoganglionosis was extended to the small intestine and the stomach.
Expression level changes in the whole gut of Ezh2 null mice
The effects of the Ezh2 deletion on the enteric nervous system were further analyzed at the molecular level in the following manner. First, we examined the expression levels of NCC developmental genes using the total RNA isolated from the guts of the Ezh2 null embryos and wild-type littermates at E18.5. Since previous studies observed over-expression of Hox genes in the BA1 cells of the Ezh2 null mutants, we also tested the expression levels of HoxA9, HoxA1, HoxA4, HoxA5, HoxB3, and HoxB5 (Fig. S5) . According to the results, the majority of the tested NCC genes were down-regulated in the Ezh2 null embryos compared to their wild-type littermates (Fig. 3) . The most significant and consistent down-regulation was observed in Phox2b (n=4, p=0.0035) and Sox10 (n=8, p=0.0239). In contrast, two genes, Zic1 (n=6, p=0.003) and Pax3 (n=6, p=0.019), were 5 to 30 fold up-regulated in the Ezh2 null embryos compared to their wild-type littermates (Fig. 3) . A slight up-regulation of HoxA9 and HoxA5
was seen in some of the Ezh2 null mutants (n=2), but the levels were not as significant as Pax3
or Zic1 (Fig. S5) . Gel electrophoresis of the PCR product from whole gut cDNA confirmed the presence of Pax3 (226 bp) and Zic1 (235 bp) expression in Ezh2 null mutants and absence of expression in its wild-type littermates (Fig. S7A) . To examine the aberrant spatiotemporal gene expression of Pax3, series of whole mount RNA in situ hybridization were performed on the E15
gut. All wild-type embryo guts did not show staining with the anti-Pax3 probe (n=6), while
Ezh2 null embryo showed staining throughout the entire gut (n=3) (Fig. S7B ).
Expression analysis and epigenetic changes in NCC genes of Ezh2 null mice in isolated myenteric plexus
To test if the changes in the expression of these NCC developmental genes are in the enteric nervous system, the myenteric plexus was isolated from P0 neonates in accordance with previously published protocols by Grundmann et al., 2015 (Fig. 4A) . The expression of Pax3 (n=3, p=0.0010) and Zic1 (n=3, p=0.0071) was consistently derepressed in the myenteric plexus of the Ezh2 null mice, while no expression was observed in the wild-type littermate control. In contrast to the qRT-PCR data from the whole gut, in which the Sox10 was seen to be downregulated in the Ezh2 null mice, a 20-fold up-regulation of Sox10 (n= 4, p=0.0263) was detected in the Ezh2 null myenteric plexus cells. Overall, Pax3, Zic1 and Sox10 are aberrantly expressed in the isolated Ezh2 null myenteric plexus cells (Fig. 4B) .
Since the H3K27me3 histone modification mark is established through Ezh2 and this modification is associated with gene repression, ChIP assays with H3K27me3 antibodies were performed on the isolated myenteric plexus. These experiments utilized the chromatin isolated from the myenteric plexus of Ezh2 null and wild-type littermates at E18.5 (Fig. 4A) . According to the results, Pax3 and Zic1 showed the most significantly (p=0.0011 and p=0.0035, respectively) reduced levels of H3K27me3 enrichment in the Ezh2 null embryos (n=6) compared to those from the wild-type littermates (n=8) (Fig. 4C) . In sum, this series of analyses indicated up-regulation of Zic1, Pax3 and Sox10, and reduced levels of H3K27me3 modifications in the promoter regions of NCC developmental genes.
Reduced neuronal and glial cells and aberrant accumulation of Sox10 in Ezh2 null myenteric plexus
To examine the number of neurons and glial cells in the myenteric plexus, the longitudinal muscle attached to myenteric plexus (LMMPs) was isolated from the ileum and the proximal colon and were stained with a neuronal marker Hu (Furness et al., 2004 ) and a glial marker GFAP. The reduced number of neuron and glial cells were visible from E16 embryos (Fig. 5) , and this pattern of reduced neuronal and glial cells in the Ezh2 null mice continued in P0
neonates ( Fig. 6 and Fig. 7 ). On average, approximately 200 neuronal cells were counted per 300µm 2 area in wild type P0 mice while approximately half of that amount of neurons in the same area was seen in the Ezh2 null myenteric plexus ranging from 39 to 138 neuronal cells (n=8, p<0.001) (Fig. 7) . Immunohistochemistry of GFAP also showed much less amount of GFAP positive cells in the Ezh2 null mice compared to its littermate control in both E16 and P0
stage myenteric plexuses (n=8, p<0.0001) (Fig. 5 and Fig. 7) .
As Sox10 is an early precursor marker for NCCs (Bondurand and Sham, 2013) , and it is one of the genes which displayed contradicting results in the expression patterns of the whole gut compared to the isolated myenteric plexus (Fig. 3 and Fig. 4) , the expression patterns of Sox10 in the myenteric plexus of P0 stage neonates were examined with immunohistochemistry.
During the enteric nervous system development, Sox10 is expressed all migrating progenitors of ENCCs, and as the cells differentiate into neuronal lineage, Sox10 is repressed in the neuronal cells and the expression of Sox10 remains only in the glial cells of the developed enteric nervous system (Kim et al., 2003, Bondurand and Sham 2013) . As expected, the Sox10 immunohistochemistry staining in Ezh2 wild type control mice also did not show much overlapping expression of Sox10 and Hu (Fig. 6 -top panel) , and almost complete overlapping expression of Sox10 and GFAP (Fig. 7 -top panel) . On the other hand, the Ezh2 null mice displayed aberrant overexpression of Sox10 proteins, some of which overlapped with Hu (Fig. 6, bottom panel, white arrow) and some of which overlapped with GFAP ( Fig. 7 -bottom panel, white arrow). Other clusters of Sox10 overexpressing cells did not overlap with any of these markers (Fig. 6, and Fig. 7) . Overall, Ezh2 null mice displayed reduced number of neuronal cells and glial cells in the myenteric plexus of E16 embryos and P0 stage neonates, and overexpression of Sox10 proteins were detected in the myenteric plexus P0 stage neonates of Ezh2 null mice.
Discussion
In the current study, we characterized the function of Ezh2 as an epigenetic modifier in the development of cranial NCCs and ENCCs. The Ezh2 null mice were viable up to birth, but died shortly after (Fig. 1) . Consistent with the previous observation, these mice displayed multiple facial deformities, which include the absence of the jaw bones, underdevelopment of the middle ear, absence of Meckel's cartilage, absence of nasofrontal plate with herniation of the brain and meninges (Fig. 1 ) (Schwarz et al., 2014; Zemke et al., 2015) . Some of the newly described cranial NCC mutant phenotypes include absence of outer ear, incomplete development of the eyelids, absence of the cornea and conjunctiva, microphthalmia, and bifid nose (Fig. 1) . In addition to the cranial NCC defects, aberrant development of ENCCs were also often seen in Ezh2 null mice (Fig. 2) . The
Ezh2 null mice displayed hypogangliosis in later stages of embryonic development (E18.5), characterized by hypoganglionosis in the distal colon and 30%-60% reduction in the stomach and small intestine enteric plexus in Ezh2 mutants ( Fig. 2 and Fig. S4 ). Gene expression analysis in the E18.5 whole gut of Ezh2 null mice showed significant reduction of Sox10 and Phox2b expression and 5 to 30 fold up-regulation of Pax3 and Zic1 expression compared to its wild-type littermates (Fig. 3) . The spatial temporal expression of Pax3 was confirmed through whole mount in situ hybridization of E14.5 gut (Fig. S7B ) and the expression of the aberrant transcripts of Pax3, Zic1 and Sox10 were further confirmed in the isolated myenteric plexus cells (Fig. 4) . In the myenteirc plexus, Sox10, which was down regulated in the whole gut seemed to also be surprisingly upregulated (Fig. 4) . The Immunohistochemistry of Ezh2 null myenteric plexus from E16 and P0 suggested reduced levels of both neuronal and glial cells and aberrant overexpression of Sox10 in P0 neonates (Figs 5, 6, and Fig. 7) .
Two possible explanations can be suggested for the outcome of the hypoganglion mutant phenotype. First, the differentiation capacity of the ENCC precursor cells in Ezh2 null mice may be lost due to de-repression of Pax3 and Zic1. In Xenopus embryos, the over-expression of Pax3
and Zic1 was shown to induce the ectopic expression of neural crest differentiation downstream genes in the ventral region (Sato et al., 2004, Hong and Saint-Jeannet, 2007) . During ENCC development, the neural plate border genes may need to be repressed through Ezh2, hence the (Wu et al., 2008) . Zic1 has also been proposed to be repressed in migrating NCCs (Sun Rhodes and Merzdorf, 2006) . However, the derepression of Pax3 and Zic1 in the Ezh2 null mice may be limited to the ENCCs, since significant upregulation of these genes were not detected in the BA1 cells of Ezh2 null mice in previous studies (Schwartz et al., 2014) . Second, in addition to Pax3 and Zic1, Sox10 was also significantly upregulated in the myenteric plexus cells. The conflicting results of Sox10 expression in the whole gut versus the myenteric plexus may be due to the overall reduced amount of NC specifier genes in the gut, but increased amount of undifferentiated cells in the myenteric plexus. Notably, aberrant expression of Sox10 has been linked to hypogangliosis in human patient studies and in mouse models (Sham et al., 2001; Southard-Smith et al., 1998; Herbarth et al., 1998; Nagashimada et al., 2012) . The immunohistochemical staining of Sox10 in Ezh2 null mice seem to favor this scenario in that the clusters of Sox10 overexpressing cells overlap with neither neuronal nor glial cells (Fig. 6 and Fig. 7 ) and seem to have adopted its own unique cell fate.
It is also possible that Hox genes are epigenetically altered in the ENS of the Ezh2 mutants, since Hox genes has been linked to megacolon phenotypes (Tennyson et al., 1993) , and combined mutations in Ret and Hox genes have been previously linked to increased penetrance of Hirschsprung's disease (Garcia-Barceló et al., 2007) . However, in the current studies, we have seen up-regulation of Pax3 and Zic1, but not HoxA9, which was one of the most significantly up-regulated genes in the BA1 cells of Ezh2 null mutants (Schwarz et al., 2014) . It is interesting that the upregulated genes between the cranial NCCs are not shared in the ENCCs.
The transcriptional levels of other Hox genes, HoxA1, HoxA4, HoxA5, HoxB3, and HoxB5,  which are involved in the enteric nervous system development (Aubin et al., 1999 , Chen et al., 2005 , Tennyson et al., 1993 , Fu et al., 2003 , Kam et al., 2014 , were also tested. However, their gene expression levels were not significantly altered in the Ezh2 null mice (Fig. S5) . Although
ChIP assays suggest reduced H3K27me3 mark in HoxA9 promoter region, it is puzzling to see no changes in gene expression. A number of factors have been suggested to play a role in affecting the transcriptional machinery of PRC2, including how the PRC2 subunits such as Suz12, Eed, and Ezh1 are assembled, and how these complexes interacts with other cofactors such as Jarid2
and Aebp2 (Aranda et al., 2015) . In addition, the removal of H3K27me3 alone have been demonstrated be insufficient to activate its downstream genes (Kashyap et al., 2011) . Future studies in comparing the Ezh2 null cranial NCCs to its ENCCs and identifying the types of transcription factors that may respond to the loss of H3K27me3 and recruit gene expression machinery to its downstream genes may help to characterize the mechanism in how Ezh2 affects NCC development.
NCCs played a significant role in vertebrate evolution, including adaptation to the environment through formation of the head, and advancement in sensory function as well as complex signaling between the gut and the brain (Gans and Northcutt, 1983; Gershon, 1997) . HoxA9 are presented as a relative value (%) to that of the input DNA normalized over a negative locus (beta actin) (y-axis). Student's t-test (two-tailed) value shows significant difference in H3K27me3 enrichment between Ezh2 null and wild-type littermates (p<0.01). 
